Efficacy of ethanol ablation as a treatment of benign head and neck cystic lesions
| Autor: | Ashley Lloyd, Joseph F. Goodman, Esther Lee, Punam Thakkar, Arjun S. Joshi, Amir Elzomor, Lilun Li, Daniel A. Benito, Isabel Park |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors Patient demographics 03 medical and health sciences Cystic lesion 0302 clinical medicine Interquartile range Otolaryngologists Sclerotherapy Medicine Humans Cyst 030223 otorhinolaryngology Head and neck Aged Retrospective Studies Ethanol ablation Ethanol business.industry Cysts Medical record Middle Aged medicine.disease Sclerosing Solutions Surgery Thyroglossal Cyst Treatment Outcome Otorhinolaryngology Ambulatory Surgical Procedures 030220 oncology & carcinogenesis Female Parotid Diseases Safety business Follow-Up Studies |
| Zdroj: | American journal of otolaryngology. 42(6) |
| ISSN: | 1532-818X |
| Popis: | Objective To evaluate the efficacy and safety of ethanol ablation in the treatment of benign head and neck cystic lesions. Methods A total of 25 patients who received ethanol ablation (EA) of head and neck cystic lesions by an otolaryngologist at a single institution between October 2017 and October 2020 were identified. Patient demographics, clinical characteristics, treatment details, and treatment outcomes at follow up visits were obtained by retrospective review of electronic medical records. Results 25 patients who underwent ethanol ablation of head and neck cystic lesions were included, with a mean age of 49.1 years old (Interquartile range (IQR),32.5–65.5 years) and 12 males (47.0%). The most common cysts treated with EA were thyroglossal duct cysts (n = 8, 32.0%) and lymphoepithelial parotid cysts (n = 7, 28.0%). The mean volume prior to treatment was 10.57 mL (IQR, 1.58–8.81 mL). Mean volume following EA was 1.30 mL (range, 0.10–0.97 mL) with 74.40% cyst reduction by volume (IQR, 48.56–96.29%) (p = 0.002). The mean time to the last follow-up was 5 months (range, 3–6 months). One patient received surgery despite treatment success to obtain a definitive diagnosis of the mass. No other patients received further surgical management. The treatment success of EA, as defined by >70% volume reduction or the resolution of symptoms, was 92.0%. All patients were satisfied with the outcome and had no reported complications. Conclusion EA is an effective and safe alternative to surgery for the treatment of head and neck cystic lesions that can be performed in an outpatient setting by an otolaryngologist. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect